Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 34

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 34
---
 common stock. This provision could prevent stockholders
from calling a special meeting because, unless certain significant stockholders were to join with them, they might not obtain the percentage
necessary to request the meeting. Therefore, stockholders holding less than 20% of the issued and outstanding common stock, without the
assistance of management, may be unable to propose a vote on any transaction that would delay, defer or prevent a change of control,
even if the transaction were in the best interests of our stockholders.

Transfer Agent

The transfer agent for our
common stock is VStock Transfer, LLC.

Listing of Securities

Our common stock is listed
on the Nasdaq Capital Market under the symbol “NDRA.”

<div align='center'>16

SELLING STOCKHOLDERS</div>

This prospectus covers the
resale by the selling stockholders of up to 2,677,680 Shares that have been or may be issued by us to the selling stockholders under
the arrangements and agreements described herein. When we refer to the “selling stockholders” in this prospectus, we mean
the persons and entities listed in the table below, and their respective pledgees, donees, permitted transferees, assignees, successors
and others who later come to hold any of the selling stockholders’ interests in the Shares. We do not know how long the selling
stockholders will hold the Shares before selling them, and we currently have no agreements, arrangements or understandings with the selling
stockholders regarding the sale of any of the Shares.

The following table sets
forth certain information regarding the beneficial ownership of shares of common stock by the selling stockholders as of October 31,
2025 and the number of shares of our common stock being offered pursuant to this prospectus.

The table below (i) lists
the selling stockholders and other information regarding the Shares beneficially owned by the selling stockholder; (ii) has been prepared
based upon information furnished to us by the selling stockholders; and (iii) to our knowledge, is accurate as of the date of this prospectus.
The selling stockholders may sell all, some or none of their Shares in this offering. The selling stockholders identified in the table
below may have sold, transferred or otherwise disposed of some or all of its Shares since the date of this prospectus in transactions
exempt from or not subject to the registration requirements of the Securities Act. Information concerning the selling stockholders may
change from time to time and,